1. Home
  2. ABVX vs HII Comparison

ABVX vs HII Comparison

Compare ABVX & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abivax SA American

ABVX

Abivax SA American

N/A

Current Price

$114.64

Market Cap

11.9B

Sector

N/A

ML Signal

N/A

Logo Huntington Ingalls Industries Inc.

HII

Huntington Ingalls Industries Inc.

N/A

Current Price

$284.64

Market Cap

11.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ABVX
HII
Founded
2013
1886
Country
France
United States
Employees
N/A
44000
Industry
Marine Transportation
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
11.5B
IPO Year
2022
2010

Fundamental Metrics

Financial Performance
Metric
ABVX
HII
Price
$114.64
$284.64
Analyst Decision
Buy
Buy
Analyst Count
13
6
Target Price
$131.31
$411.33
AVG Volume (30 Days)
801.6K
369.9K
Earning Date
03-23-2026
05-05-2026
Dividend Yield
N/A
1.52%
EPS Growth
N/A
10.24
EPS
N/A
9.06
Revenue
N/A
$12,484,000,000.00
Revenue This Year
$52.14
$4.82
Revenue Next Year
$4,132.27
$6.28
P/E Ratio
N/A
$32.04
Revenue Growth
N/A
8.23
52 Week Low
$69.81
$263.62
52 Week High
$148.83
$460.00

Technical Indicators

Market Signals
Indicator
ABVX
HII
Relative Strength Index (RSI) 43.49 39.96
Support Level $107.67 $286.97
Resistance Level $129.00 $299.84
Average True Range (ATR) 3.63 7.50
MACD -0.47 -2.79
Stochastic Oscillator 35.04 10.04

Price Performance

Historical Comparison
ABVX
HII

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships, including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: